Merrimack Pharmaceuticals Inc (MACK)
14.74
+0.01
(+0.07%)
USD |
NASDAQ |
Apr 26, 12:31
Merrimack Pharmaceuticals Total Assets (Quarterly): 19.19M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 19.19M |
September 30, 2023 | 19.30M |
June 30, 2023 | 19.45M |
March 31, 2023 | 19.64M |
December 31, 2022 | 19.84M |
September 30, 2022 | 13.64M |
June 30, 2022 | 14.06M |
March 31, 2022 | 14.64M |
December 31, 2021 | 14.75M |
September 30, 2021 | 15.30M |
June 30, 2021 | 15.86M |
March 31, 2021 | 16.44M |
December 31, 2020 | 16.78M |
September 30, 2020 | 18.96M |
June 30, 2020 | 19.68M |
March 31, 2020 | 21.34M |
December 31, 2019 | 20.08M |
September 30, 2019 | 24.84M |
June 30, 2019 | 45.04M |
March 31, 2019 | 74.35M |
December 31, 2018 | 88.54M |
September 30, 2018 | 103.92M |
June 30, 2018 | 80.23M |
March 31, 2018 | 97.50M |
December 31, 2017 | 117.33M |
Date | Value |
---|---|
September 30, 2017 | 197.85M |
June 30, 2017 | 213.45M |
March 31, 2017 | 68.64M |
December 31, 2016 | 81.48M |
September 30, 2016 | 118.41M |
June 30, 2016 | 150.02M |
March 31, 2016 | 192.93M |
December 31, 2015 | 234.88M |
September 30, 2015 | 102.68M |
June 30, 2015 | 105.04M |
March 31, 2015 | 127.02M |
December 31, 2014 | 158.51M |
September 30, 2014 | 188.60M |
June 30, 2014 | 129.81M |
March 31, 2014 | 164.98M |
December 31, 2013 | 192.42M |
September 30, 2013 | 224.24M |
June 30, 2013 | 107.32M |
March 31, 2013 | 127.32M |
December 31, 2012 | 148.97M |
September 30, 2012 | 123.21M |
June 30, 2012 | 138.71M |
March 31, 2012 | 64.45M |
December 31, 2011 | 85.30M |
September 30, 2011 | 89.25M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
13.64M
Minimum
Sep 2022
45.04M
Maximum
Jun 2019
19.41M
Average
19.19M
Median
Dec 2023
Total Assets (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 9.034M |
Palatin Technologies Inc | 13.55M |
iBio Inc | 34.02M |
Theriva Biologics Inc | 55.22M |
Oragenics Inc | 4.966M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 0.441M |
Shareholders Equity (Quarterly) | 18.75M |